Neutropenia and efficacy outcomes in patients with refractory mCRC: A post-hoc analysis of the phase III SUNLIGHT trial

被引：0

作者：

Prager, G. ^{[1
]}

Tabernero, J. ^{[2
]}

Fakih, M. ^{[3
]}

Ciardiello, F. ^{[4
]}

Van Cutsem, E. ^{[5
]}

Roby, L. ^{[6
]}

Yao, W. ^{[7
]}

Choucair, E. ^{[8
]}

Taieb, J. ^{[9
]}

机构：

[1] Univ Kliniken MedUni Wien AKH Wien, Dept Med 1, Vienna, Austria

[2] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain

[3] City Hope Comprehens Canc Ctr, Med Oncol & Therapeut Res, Duarte, CA USA

[4] Univ Campania Luigi Vanvitelli, Dipartimento Med Precis, Naples, Italy

[5] UZ Leuven Univ Hosp Leuven, Digest Oncol Dept, Campus Gasthuisberg, Leuven, Belgium

[6] IRIS, Dept Oncol, Suresnes, France

[7] Servier Pharmaceut, Dept Clin Res, Boston, MA USA

[8] Lab Servier SAS, Med Affairs, Suresnes, France

[9] Hop European George Pompidou, Gastroenterol & Digest Oncol Dept, Paris, France

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.05.046

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

35P

引用

页码：S18 / S19

页数：2

共 50 条

[31] Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial [J].

Kontoyiannis, Dimitrios P. ;

Selleslag, Dominik ;

Mullane, Kathleen ;

Cornely, Oliver A. ;

Hope, William ;

Lortholary, Olivier ;

Croos-Dabrera, Rodney ;

Lademacher, Christopher ;

Engelhardt, Marc ;

Patterson, Thomas F. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (03) :757-763

[32] Efficacy and Safety of Galcanezumab as a Preventive Treatment for Episodic Migraine in South Korean Patients: A Post-Hoc Analysis of a Phase 3 Clinical Trial [J].

Kim, Byung-Kun ;

Cho, Soo-Jin ;

Han, Jeong Hee ;

Dell'Agnello, Grazia ;

Panni, Tommaso ;

Kim, Manho ;

Oh, Kyungmi ;

Moon, Heui-Soo ;

Chu, Min Kyung .

JOURNAL OF CLINICAL NEUROLOGY, 2023, 19 (05) :483-494

[33] The Burden of White Matter Hyperintensities on Function Outcomes in Patients Treated for Acute Ischemic Stroke: A Post-Hoc Analysis of the IMS-III Trial [J].

Mehta, Amit ;

Elmashad, Ahmed ;

Narula, Reshma ;

Broderick, Joseph P. ;

de Havenon, Adam H. .

STROKE, 2024, 55

[34] Effect of Age on the Safety and Efficacy of Selinexor in Patients with Relapsed Refractory Multiple Myeloma: A Post-hoc Analysis of the STORM Study [J].

Gavriatopoulou, Maria ;

Vogl, Dan T. ;

Nooka, Ajay ;

Dingli, David ;

Cole, Craig ;

Moreau, Philippe ;

Huff, Carol ;

Yee, Andrew ;

Dimopoulos, Meletios A. ;

Lonial, Sagar ;

Richardson, Paul G. ;

Stewart, Keith ;

Chari, Ajai ;

Richter, Joshua ;

Biran, Noa ;

Siegel, David S. ;

Liu, Jianjun ;

Joshi, Anita ;

Shah, Jatin ;

Shacham, Sharon ;

Kauffman, Michael ;

Jagannath, Sundar .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10) :E117-E118

[35] Post-hoc analysis of ACCORD-BP trial [J].

Kang, Seema .

LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (11) :850-850

[36] Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: A phase III post-hoc analysis [J].

Glauser, Tracy ;

Laurenza, Antonio ;

Yang, Haichen ;

Williams, Betsy ;

Ma, Tony ;

Fain, Randi .

EPILEPSY RESEARCH, 2016, 119 :34-40

[37] COMPARING THE EFFECT OF NOVOTTF TO BEVACIZUMAB IN RECURRENT GBM: A POST-HOC SUB-ANALYSIS OF THE PHASE III TRIAL DATA [J].

Ram, Zvi ;

Wong, Eric T. ;

Gutin, Philip H. .

NEURO-ONCOLOGY, 2011, 13 :52-52

[38] Evaluating the efficacy of vilazodone in achieving remission in patients with major depressive disorder: post-hoc analyses of a phase IV trial [J].

Citrome, Leslie ;

Gommoll, Carl P. ;

Tang, Xiongwen ;

Nunez, Rene ;

Mathews, Maju .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (02) :75-81

[39] IVARMACITINIB REDUCES THE NEED FOR CONCOMITANT MEDICATION IN MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS PATIENTS: A POST-HOC ANALYSIS FROM A PHASE III TRIAL [J].

Liu, H. ;

Song, L. ;

Li, J. .

ANNALS OF THE RHEUMATIC DISEASES, 2025, 84

[40] The Impact of Anlotinib on Quality of Life in Patients with Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303) [J].

Si, X. ;

Zhang, L. ;

Wang, H. ;

Zhang, X. ;

Wang, M. ;

Han, B. ;

Li, K. ;

Wang, Q. ;

Shi, J. ;

Wang, Z. ;

Cheng, Y. ;

He, J. ;

Shi, Y. ;

Chen, W. ;

Wang, X. ;

Luo, Y. ;

Nan, K. ;

Jin, F. ;

Li, B. ;

Chen, Y. ;

Zhou, J. ;

Wang, D. .

JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) :S505-S505

← 1 2 3 4 5 →